Pharma BD Deal Intelligence
Ranks computed across 828 graded deals (Critic + Outcome Score both present).
Pfizer and Allergan confirmed Monday they will merge to form the worlds biggest drug company by sales, in a deal that is mostly, if not exclusively, about tax.…
The tax inversion is merely a transfer of future revenues from the US Treasury to current Pfizer and Allergan shareholders, questioning whether genuine joint…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
Pfizer and Allergan agreed to merge in a $160 billion deal that would have created the world's largest pharmaceutical company. The deal was terminated in April 2016 after the US Treasury Department issued new rules targeting tax inversions.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Pfizer Inc. / Allergan plc (this deal) | 2015 | $160.0B | 29 |
| Pfizer Inc. / BioNTech SE | 2020 | $748M | 100 |
| Pfizer Inc. / FoldRx Pharmaceuticals | 2010 | — | 99 |
| Pfizer Inc. / Medivation Inc. | 2016 | $14.0B | 86 |
| Pfizer Inc. / Wyeth | 2009 | $68.0B | 86 |
| Pfizer Inc. / Warner-Lambert Company | 2000 | $90.0B | 83 |
| Pfizer Inc. / Arvinas, Inc. | 2021 | $2.4B | 77 |
← Browse all deals · How we score deals
More: 2015 deals · Pfizer Inc. deals · Gastroenterology deals